ACT 242, HB254 HD2 SD1 CD1, 7/12/2016

Posted on Jul 13, 2016 in 2016 Acts


Allows for and regulates the dispensing of interchangeable biological products. Requires pharmacists to inform consumers of interchangeable biological products from the Hawaii list when filling a prescription order and to communicate the product name and manufacturer to the practitioner after dispensing the product. Repeals the Drug Product Selection Board. (HB254 CD1)

ACT 242, HB254 HD2 SD1 CD1